FDA panel gives thumbs-up to GSK''s OTC anti-obesity pill

... GlaxoSmithKline (GSK) Consumer Healthcare''s Alli, a low dosage form of the anti-obesity drug Xenical, has been given the go-ahead by a US Food and Drug Administration (FDA) panel for over-the-counter (OTC) sale. The panel voted 11-3 in favor of making the drug, which goes by the generic name orlistat, available without a prescription. If the FDA accepts the panel''s recommendation, Alli would become the first ever OTC weight-loss pill. ...